EU and EUREKA Launched Eurostars Programme for Research-Performing SMEs

EurostarsEurope has taken "another step in the realisation of the European Research Area, this time to the benefit of SMEs", according to EU Science and Research Commissioner Janez Potocnik, who helped to launch EUREKA's Eurostars programme. The programme will provide financial support, from both EU and the EUREKA member country funds, to Europe's young and innovative companies, described by Mr Potocnik as the 'lifeblood' of Europe's economy. The programme is aimed specifically at a niche market of research and innovation-performing businesses that fulfil the EU-adopted definition of an SME, are based in a country participating in Eurostars, and that invest 10% or more of their annual turnover in research.

"SMEs are the driving motor of the European economy because they are flexible. They can adapt quickly to the needs of the market," said the Commissioner.

Importantly, the initiative has been welcomed by the SME community. Speaking at the launch, chairman of the European Federation of high-tech SMEs, Emmanuel Leprince, spoke of his 'high expectations' for the programme. He also talked of a 'glass ceiling' that is preventing most SMEs from reaching their full potential. Eurostars will help these young companies, so often considered by investors as the 'dangerous option', to get a foot on the ladder.

The attraction of Eurostars is that it is designed specifically for SMEs involved in research, said Mr Leprince. "The Commission tackles red tape, regulations, standards etc. These are all important issues, but they are not the specific problems of SMEs," he explained.

Some SME representatives would however like to see the criteria for participation widened so that more companies can benefit. Ullrich Schröder, research and development (R&D) advisor at the European craft and SME employers' organisation (UEAPME), said that the number of SMEs investing 10% or over in research is quite small, and that the barrier should be lowered to 5% in line with the definition of a high-tech SME used by the Organisation for Economic Cooperation and Development (OECD).

Representing the Slovenian Presidency of EUREKA, Ales Mihelic, General Director of the Slovenian Ministry of Higher Education, Science and Technology, conceded that 10% is quite high, but pointed out that EUREKA has made it easier for more companies to participate by saying that they can also invest 10% of their full-time equivalent (FTE) in R&D.

Mr Potocnik highlighted how Eurostars will complement existing EU initiatives intended to support SMEs conducting research. Under the Sixth Framework Programme (FP6) the Commission set the target of having SMEs make up 15% of project participants. This target proved difficult to meet in some areas however. Under FP7, the Commission has simplified administrative procedures, increased the funding of SME projects from 50% to 75% of the project's cost, and introduced the guarantee fund. All of these measures are intended to make it easier for SMEs to participate in FP7.

But as the Commissioner pointed out, "In FP7 Cooperation projects, SMEs aren't usually leading the projects." Eurostars will enable SMEs to do just that, benefitting from €100 million in Commission funding and €300 million from 22 EU Member States and five countries associated to FP7. This capital is expected to attract a further €400 million in private investment.

"Eurostars fills a gap that was existing, using tools that were on our market but not used in this combination," said Mr Potocnik. The Commission's participation comes under Article 169 of the EU Treaty, which allows for the participation of the Community in research programmes run jointly by a number of EU Member States.

The Commissioner referred to these new and closer links between EUREKA and the framework programmes as a marriage. Alluding to questions over the Commission's commitment to funding Eurostars beyond its initial six-year timeframe, he said: "As we all know, in a marriage, it is not enough to say 'yes' only at the beginning. You have to show that you mean it constantly."

The imagery continued as the Commissioner concluded his speech, claiming that he was happy to be the best man at this marriage, and wishing Eurostars a long and happy life, with lots of healthy SMEs.

For further information, please visit:
http://www.eurostars-eureka.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...